Show items per page
Elements: 6
Page 1 on 1
 TitleAuthors / EditorsDate
add to browser selection
Impact of anti-insulin antibodies on islet transplantation outcome: data from the GRAGIL Network Lablanche, Sandrine; Borot, Sophie; Thaunat, Olivier; Bayle, Francois; ... Benhamou, Pierre Y 2014
add to browser selection
Respective effects of oxygen and energy substrate deprivation on beta cell viability Lablanche, Sandrine; Cottet-Rousselle, Cécile; Argaud, Laurent; Laporte, Camille; ... Fontaine, Eric 2015
add to browser selection
Five-Year Metabolic, Functional, and Safety Results of Patients With Type 1 Diabetes Transplanted With Allogenic Islets Within the Swiss-French GRAGIL Network Lablanche, Sandrine; Borot, Sophie; Wojtusciszyn, Anne; Bayle, Francois; ... Benhamou, Pierre-Yves 2015
add to browser selection
Alloimmune Monitoring after Islet Transplantation: A Prospective Multicenter Assessment of 25 Recipients Delaune, Vaihere; Toso, Christian; Benhamou, Pierre-Yves; Wojtusciszyn, Anne; ... Lacotte, Stéphanie 2016
add to browser selection
Randomised, prospective, medico-economic nationwide French study of islet transplantation in patients with severely unstable type 1 diabetes: the STABILOT study protocol Lablanche, Sandrine; David-Tchouda, Sandra; Margier, Jennifer; Schir, Edith; ... Benhamou, Pierre-Yves 2017
add to browser selection
Islet transplantation versus insulin therapy in patients with type 1 diabetes with severe hypoglycaemia or poorly controlled glycaemia after kidney transplantation (TRIMECO): a multicentre, randomised controlled trial Lablanche, Sandrine; Vantyghem, Marie-Christine; Kessler, Laurence; Wojtusciszyn, Anne; ... Benhamou, Pierre-Yves 2018